Women’s health is more than just fertility.
Hormones influence far more than reproduction. They play important roles in neurological function, metabolism, cardiovascular health, bone density, musculoskeletal health, and immune regulation, among other physiological processes.
Research increasingly reveals the complex relationships between reproductive hormones and wider physiological health. However, important questions remain about the mechanisms underlying these relationships, differences between individuals, and their implications for women's health across the lifespan.
While some relationships are well established, others remain emerging or incompletely understood. Together, they highlight the importance of more rigorous, sex-specific research into female physiology.
Below, we highlight published scientific literature examining the relationships between reproductive hormones and seven areas of physiological and psychological health, spanning established findings, emerging evidence, and questions that remain unanswered.
Explore the research
-
Reproductive hormones influence neurological processes involved in mood, cognition, and emotional regulation. Research has identified several relationships between hormonal fluctuations and neuropsychiatric health:
Premenstrual Dysphoric Disorder (PMDD): PMDD is characterized by severe psychological and emotional symptoms during the late luteal phase, when estrogen and progesterone concentrations decline before menstruation. Research suggests that PMDD involves altered neurological sensitivity to normal hormonal fluctuations, rather than abnormal hormone levels themselves.
Attention-Deficit/Hyperactivity Disorder (ADHD): Emerging research suggests that ADHD symptoms may worsen during the late luteal and premenstrual phases, potentially associated with declining estrogen concentrations. Estrogen influences dopamine signaling, which plays an important role in attention and executive function. However, individual responses vary, and research is still emerging.
Addiction and substance use: Studies have investigated how estrogen and progesterone influence reward processing and substance cravings. A systematic review of addictive behaviors across the menstrual cycle identified increased nicotine use during premenstrual and menstrual phases, while other research has investigated the influence of ovarian hormones on relapse vulnerability, including around ovulation. Findings vary by substance and study population, and further research is needed to establish consistent patterns.
-
Estrogen and progesterone interact with gastrointestinal function, influencing gut motility, visceral sensitivity, and potentially the composition of the gut microbiome.
Irritable Bowel Syndrome (IBS): Research has identified differences in IBS presentation and symptom severity between men and women. A study of 102 women with IBS found that constipation was more frequently reported during the luteal phase, when progesterone concentrations are elevated, while gastrointestinal symptoms and disruption to daily activities were particularly pronounced during menstruation.
Polyendocrine Metabolic Ovarian Syndrome (PMOS): Research has identified differences in gut microbial composition among women with PMOS and is investigating potential bidirectional relationships between the microbiome, metabolic health, and reproductive hormone regulation. Similar relationships are being explored in endometriosis. Unlike naturally cycling populations, individuals with PMOS may experience irregular or absent ovulation, making conventional cycle-phase patterns less applicable.
-
Reproductive hormones influence sleep regulation, thermoregulation, and circadian physiology, with several measurable changes occurring across the menstrual cycle.
Body temperature: Following ovulation, rising progesterone concentrations produce a thermogenic effect, increasing basal body temperature during the luteal phase. This elevation generally persists until progesterone levels decline before menstruation. These temperature changes have been documented alongside menstrual-cycle changes in sleep physiology.
Sleep architecture: Research has identified differences in sleep physiology between menstrual phases. During the progesterone-dominant luteal phase, studies have observed increased sleep spindle activity and, in some populations, modest reductions in rapid eye movement (REM) sleep compared with the follicular phase. However, findings concerning REM sleep are not consistent across studies.
Sleep quality: Women experiencing premenstrual symptoms frequently report poorer sleep during the late luteal phase and menstruation, when reproductive hormone concentrations are declining. In contrast, objective sleep continuity often remains relatively stable across the cycle in otherwise healthy, asymptomatic women.
-
Reproductive hormones participate in metabolic regulation, influencing energy expenditure, glucose metabolism, and insulin sensitivity. Research suggests that several metabolic parameters vary across the menstrual cycle.
Energy expenditure: Resting metabolic rate may increase modestly during the luteal phase, when progesterone concentrations are elevated. A systematic review and meta-analysis investigated differences in resting metabolic rate across the menstrual cycle, although the magnitude and consistency of these changes vary between individuals and studies.
Insulin resistance: Research suggests that insulin sensitivity may change across the menstrual cycle. The BioCycle Study, which followed 257 healthy premenopausal women, identified an increase in measured insulin resistance from the mid-follicular to early luteal phase, followed by a slight decline during the late luteal phase. These findings suggest a relationship between changing reproductive hormone concentrations and glucose regulation, although the mechanisms remain under investigation.
Menopause and metabolic health: Declining estrogen concentrations during the menopausal transition are associated with changes in body composition, fat distribution, and metabolic regulation. Research into reproductive hormones and metabolic health has explored how hormonal changes contribute to insulin sensitivity and longer-term metabolic risk, alongside aging and other physiological factors.
-
Estrogen and progesterone influence musculoskeletal physiology, including muscle function, connective tissue properties, and bone metabolism. Researchers have investigated whether changes in hormone concentrations across the menstrual cycle correspond with differences in strength and injury susceptibility.
Ligament laxity and ACL injuries: Estrogen concentrations typically peak shortly before ovulation. A systematic review and meta-analysis identified greater anterior cruciate ligament (ACL) laxity during the ovulatory phase compared with the follicular phase. Several studies also suggested lower ACL injury occurrence during the luteal phase.
Muscular strength: Some research suggests that measures of muscular strength vary across menstrual phases. A 2024 systematic review and meta-analysis identified higher isometric strength during the late follicular phase, when estrogen concentrations are rising, and higher isokinetic strength around ovulation. However, other systematic reviews have found minimal or inconsistent changes, highlighting the need for further investigation.
Perceived athletic performance: Research involving elite female athletes has identified differences in perceived performance, fatigue, and physical symptoms across the menstrual cycle, particularly during menstruation and the late luteal phase. These findings suggest that subjective exercise experiences may change alongside hormonal fluctuations, even where objective performance differences are small or inconsistent.
Bone health: Estrogen plays an essential role in regulating bone remodeling and maintaining bone density. Its decline during menopause is associated with accelerated bone loss and increased osteoporosis risk, demonstrating the importance of reproductive hormones to skeletal health beyond the menstrual cycle.
-
Reproductive hormones interact with immune function, influencing inflammatory signaling, immune-cell activity, and immune responses within reproductive tissues. Research has identified several changes across menstrual phases.
Menstruation and inflammation: Menstruation is an inflammatory process involving the breakdown and shedding of the endometrial lining. Research has investigated whether this localized inflammatory activity is accompanied by changes in circulating inflammatory markers, and how these processes may relate to inflammatory conditions such as endometriosis.
Luteal-phase immune changes: During the luteal phase, when progesterone concentrations are elevated, researchers have identified changes in immune activity. A 2023 systematic review and meta-analysis found higher concentrations of several innate immune-cell populations during the luteal phase compared with the follicular phase, although other inflammatory markers showed little or inconsistent variation.
Reproductive tract immunity: A 2022 systematic review and individual-participant-data meta-analysis identified lower concentrations of several immune mediators in cervicovaginal secretions during the luteal phase, including certain antibodies, chemokines, and interleukins. These findings suggest that local immune protection varies across the menstrual cycle, although they do not establish a universal increase in infection risk during any particular phase.
-
Reproductive hormones influence cardiovascular physiology, including vascular function, blood pressure regulation, and autonomic nervous system activity. Their changing concentrations may contribute to measurable differences across menstrual phases.
Vascular function: Estrogen supports endothelial function and promotes vasodilation, the relaxation of blood vessels that helps regulate blood flow. Some research suggests that these effects may be more pronounced during the late follicular phase, when estradiol concentrations rise toward their preovulatory peak. However, vascular responses also depend on other hormones and individual physiological factors.
Heart rate variability (HRV): HRV measures variation in the intervals between heartbeats and provides information about autonomic nervous system activity. A systematic review and meta-analysis of 37 studiesidentified higher measures of cardiac vagal activity during the follicular phase, followed by lower values during the luteal phase. A 2026 review of wearable-derived HRV also identified generally higher HRV earlier in the menstrual cycle and lower values toward its end. These differences reflect changes in autonomic regulation and do not necessarily indicate changes in cardiovascular disease risk.
Menstrual characteristics and cardiovascular health: Epidemiological research has identified associations between irregular menstrual cycles, shorter cycle lengths, and certain cardiovascular outcomes. A prospective UK Biobank study involving more than 58,000 women investigated these relationships, suggesting that menstrual characteristics may provide information about broader cardiovascular and metabolic health, although the associations are not necessarily causal.
Menopause and cardiovascular risk: The menopausal transition involves a sustained decline in ovarian estrogen production and is associated with changes in vascular function, lipid metabolism, and cardiovascular risk. Research into estrogen and cardiovascular physiology highlights the importance of studying reproductive hormones across the lifespan, while recognizing the contribution of aging and other physiological factors.
